𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-Year outcomes

✍ Scribed by Xue-Kui Liu; Yong Su; Naresh Jha; Ming-Huan Hong; Hai-Qiang Mai; Wei Fan; Zong-Yuan Zeng; Zhu-Ming Guo


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
100 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Our aim in this study was to investigate the value of the submandibular salivary gland transfer procedure in prevention of radiation‐induced xerostomia in patients with nasopharyngeal carcinoma (NPC).

Methods

In all, there were 70 patients, consisting of a test group (36 patients) and a control group (34 patients) in a nonrandomized fashion. In the test group, the submandibular salivary gland was transferred to submental space before radiotherapy (XRT) and shielded. Salivary gland functions were evaluated by the amount of saliva and a quality of life questionnaire before and after XRT and 3 and 60 months after XRT.

Results

At 5 years, the trapping and excretion functions of salivary gland were significantly better in the test group (p = .000 and p = .000). The mean weight of saliva after XRT was heavier (1.65 g vs 0.73 g, p = .000), and the incidence of xerostomia was lower in the test group, with no difference in 5‐year survival and neck nodal recurrence between the 2 groups.

Conclusions

Salivary gland transfer procedure prevents XRT‐induced xerostomia and improves quality of life of patients with NPC. © 2010 Wiley Periodicals, Inc. Head Neck, 2010


📜 SIMILAR VOLUMES


Functional outcomes related to the preve
✍ Jana M. Rieger; Naresh Jha; Judith A. Lam Tang; Jeffrey Harris; Hadi Seikaly 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract ## Background Xerostomia has a devastating impact on oral function and quality of life in patients who receive radiation treatment for head and neck cancer. The purpose of this study was to examine functional outcomes related to 2 saliva‐sparing treatments: (1) oral pilocarpine during